annual meeting program - American Society of Clinical Oncology

11:30 AM - 12:45 PM
EDUCATION SESSIONS
Addressing the Cost of Cancer Care with Patients: Practice-based Strategies
for Communicating the “New Bad News”
Location: E353
CME credit: 1.25
Track(s): Professional Development; Health Services Research; Practice Management and
Information Technology
Lidia Schapira, MD—Chair
Massachusetts General Hospital
Communication about Cost of Cancer Care
Deborah Schrag, MD
Dana-Farber Cancer Institute
Communicating the Costs and Benefits of Medical Interventions
Anthony Back, MD
Seattle Cancer Care Alliance
Inside the Patient-Physician Encounter: Communication and Value
Are We Asking Too Much? The Challenges of Mandatory Research Biopsies
within Clinical Trials
Location: S100b
CME credit: 1.25
Track(s): Ethics; Clinical Trials; Developmental Therapeutics
Jeffrey M. Peppercorn, MD, MPH—Chair
Duke University Medical Center
The Ethical Framework: Can We Pursue Mandatory Research Biopsy under Select
Circumstances?
Eric P. Winer, MD
Dana-Farber Cancer Institute
What Can We Learn? The Scientific Justification for Consideration of Mandatory Research
Biopsy within Some Clinical Trials
Michael Katz
Eastern Cooperative Oncology Group, Patient Advisory Board
Are We Asking Too Much? Ethical Concerns over Mandatory Research Biopsy: Concerns over
Coercion
Evolving Standards of Care in Metastatic Castration-resistant Prostate Cancer
Location: E Arie Crown Theater
CME credit: 1.25
Track(s): Genitourinary Cancer; General Oncology; Geriatric Oncology; Patient and Survivor
Care
Michael J. Morris, MD—Chair
Memorial Sloan-Kettering Cancer Center
Phase III Trial Results and the Impact on Standard of Care and Trial Design
Kim N. Chi, MD
British Columbia Cancer Agency
Second-line Treatment after Docetaxel
Monday, June 7, 2010
Evan Y. Yu, MD
University of Washington
Bone-directed Therapy for Prostate Cancer: Present Standards and Potential New Options
355
MONDAY